“Intermediate Results of the Prospective Randomized Controlled Trial VOG-01: ‘Evaluation of the Efficacy of Neoadjuvant Combination Hormone Therapy in Premenopausal Patients With ER+ HER2- Breast Cancer’”. 2022. Voprosy Onkologii 68 (3): 354-61. https://doi.org/10.37469/0507-3758-2022-68-3-354-361.